Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim vs rhTPO to Accelerate Platelet Engraftment After Umbilical Cord Blood Transplantation
ChiCTR2500115443Phase 2Not yet recruiting
- Sponsor
- The Seventh Affiliated Hospital, Sun Yat-Sen University
- Start
- Dec 2025
- Modality
- Recombinant Proteins and Enzymes, Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial in Delayed platelet engraftment (DPE), hematopoietic malignancies and bone marrow failure comparing Romiplostim Group with rhTPO Group (2 arms). Primary endpoint: Time to Platelet Engraftment. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
romiplostimrecombinant human thrombopoietin
03
Conditions
Delayed platelet engraftment (DPE)hematopoietic malignanciesbone marrow failure
Beyond the preview
Go deeper on ChiCTR2500115443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500115443.